Neuropathology and Applied Neurobiology
© British Neuropathological Society
Edited By: Dr Stephen Wharton
Impact Factor: 3.802
ISI Journal Citation Reports © Ranking: 2011: 13/79 (Pathology); 34/192 (Clinical Neurology); 70/244 (Neurosciences)
Online ISSN: 1365-2990
Muscle Disorders, June 2011
This virtual issue brings together a selection of papers on muscle disease published in Neuropathology and Applied Neurobiology from 2008 to 2011. The selection includes a major review on inflammatory muscle disorders and papers on diagnostic methods, myofibrillar myopathies, dystrophies and childhood myopathies.
Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression
V. Arechavala-Gomeza, M. Kinali, L. Feng, et al.
Expression of mutant ubiquitin (UBB 1) and p62 in myotilinopathies and desminopathies
M. Olivé, F. W. Van Leeuwen, A. Janué, et al.
A series of Chinese patients with desminopathy associated with six novel and one reported mutations in the desmin gene
D. Hong, Z. Wang, W. Zhang, et al.
Muscle histopathology in myasthenia gravis withantibodies against MuSK and AChR
S. Martignago, M. Fanin, E. Albertini, et al.
Childhood spinal muscular atrophy induces alterations in contractile and regulatory protein isoform expressions
L. Stevens, B. Bastide, C. A. Maurage, et al.
Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1
L.-E. Thornell, M. Lindstöm, V. Renault, et al.
The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients’ muscles
R. Massa, M. B. Panico, S. Caldarola, et al.
Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy
A. Cozzoli, J.-F. Rolland, R. F. Capogrosso, et al.
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization J. A. Bevilacqua, N. Monnier, M. Bitoun, et al.
Brain Tumours, August 2010
This virtual issue brings together a selection of papers on neuro-oncology published in Neuropathology and Applied Neurobiology since 2009. This collection includes a review on TNF-related apoptosis ligand and original papers on the molecular pathology and pathogenesis of gliomas and meningiomas.
Review: On TRAIL for malignant glioma therapy?
M. A. Kuijlen, E. Bremer, J. J. A. Mooij et al
The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells
K. Zscharnack, R. Kessler, F. Bleichert et al
Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration
S. Mertsch, M. Becker, A. Lichota et al
Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype
T.-C. A. Johannessen, J. Wang, K.-O. Skaftnesmo et al
Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma
A. Idbaih, J. Aimard, B. Boisselier et al
Diagnostic value of WT1 in neuroepithelial tumours
J. Schittenhelm, R. Beschorner, P. Simon et al
Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence
O. Küster, P. Simon, M. Mittelbronn et al
The microglial/macrophagic response at the tumour–brain border of invasive meningiomas
S. Grund, J. Schittenhelm, F. Roser et al
Neuroinflammation, February 2010
Edited by Dr Stephen Wharton
This virtual issue puts together a selection of papers related to neuroinflammatory processes in the nervous system published recently in Neuropathology and Applied Neurobiology. They include papers on multiple sclerosis and demyelination, on models of demyelinating disorders and on mechanisms relevant to neuroinflammatory processes.
Abundant extracellular myelin in the meninges of patients with multiple sclerosis
E.-J. Kooi, J. van Horssen, M. E. Witte, S. Amor, L. Bø, C. D. Dijkstra, P. van der Valk, J. J. G. Geurts
Review: Mitochondria and disease progression in multiple sclerosis
D. Mahad, H. Lassmann and D. Turnbull
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination
M. Lindner, S. Heine, K. Haastert, N. Garde, J. Fokuhl, F. Linsmeier, C. Grothe, W. Baumgärtner, M. Stangel
Remyelination can be extensive in multiple sclerosis despite a long disease course
R. Patani, M. Balaratnam, A. Vora, R. Reynolds
Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation
E. East, D. Gverić, D. Baker, G. Pryce, H. R. Lijnen, M. L. Cuzner
Lesional accumulation of RhoA cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis
Z. Zhang, J. Schittenhelm, R. Meyermann, H. J. Schluesener
Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells
R. Ulrich, F. Seeliger, M. Kreutzer, P.-G. Germann, W. Baumgärtner
Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain
M. Cosenza-Nashat, M.-L. Zhao, H.-S. Suh, J. Morgan, R. Natividad, S. Morgello, S. C. Lee
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology
R. O. Carare, M. Bernardes-Silva, T. A. Newman, A. M. Page, J. A. R. Nicoll, V. H. Perry, R. O. Weller